| PLTR |
Report |
Revenue |
BEAT |
pred ~$1.835B vs. cons $1.814B |
MEDIUM |
| PLTR |
Report |
U.S. Commercial Revenue |
BEAT |
pred ~$730M vs. cons $718M |
MEDIUM |
| PLTR |
Report |
Adjusted Operating Income |
BEAT |
pred ~$1.100B vs. cons $1.082B |
MEDIUM |
| PLTR |
Guide |
Revenue (Q3 2026) |
BETTER |
guide ~$2.030-$2.040B vs. cons $2.002B |
MEDIUM |
| PLTR |
Guide |
Adjusted Operating Income (Q3 2026) |
BETTER |
guide ~$1.190-$1.200B vs. cons $1.165B |
MEDIUM |
| PLTR |
Guide |
Revenue (FY 2026) |
BETTER |
guide ~$7.820-$7.840B vs. cons $7.740B |
MEDIUM |
| PLTR |
Guide |
U.S. Commercial Revenue (FY 2026) |
BETTER |
guide >$3.300B vs. cons $3.221B |
MEDIUM |
| PLTR |
Guide |
Adjusted Operating Income (FY 2026) |
BETTER |
guide ~$4.650-$4.670B vs. cons $4.566B |
MEDIUM |
| PLTR |
Return |
Day-1 residual (stock − beta × S&P 500) |
+6.0% |
— |
LOW |
| PLTR |
Return |
5-day cumulative residual |
+9.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — forward revenue and margin revisions |
LOW |